Cuppens, K., Byers, L. A., Goto, Y., Ardizzoni, A., Paz-Ares, L. G., Zhou, C., Dowlati, A., Cooper, A. J., Bar, J., Lee, S., Jahchan, N., Zhao, Y., Meiman, D., Fang, F., Rivell, G., Palenski, T., Chiang, A. C. (2026). SEZanne: A phase 2 randomized, open-label, multicenter study to evaluate the optimal dose, safety, and efficacy of ABBV-706 in combination with atezolizumab (atezo) versus standard of care (SOC) in patients (pts) with previously untreated extensive-stage (ES) small cell lung cancer (SCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps8135